首页> 外文期刊>BMC Pulmonary Medicine >Prevalence and management of chronic breathlessness in COPD in a tertiary care center
【24h】

Prevalence and management of chronic breathlessness in COPD in a tertiary care center

机译:三级护理中心慢性阻塞性肺病的患病率和管理

获取原文
           

摘要

Breathlessness is the prominent symptom of chronic obstructive pulmonary disease (COPD). Despite optimal therapeutic management including pharmacological and non-pharmacological interventions, many COPD patients exhibit significant breathlessness. Chronic breathlessness is defined as breathlessness that persists despite optimal treatment of the underlying disease. Because of the major disability related to chronic breathlessness, symptomatic treatments including opioids have been recommended by several authors. The prevalence of chronic breathlessness in COPD and its management in routine clinical practice have been poorly investigated. Our aim was to examine prevalence, associated characteristics and management of chronic breathlessness in patients with COPD recruited in a real-life tertiary hospital-based cohort. A prospective study was conducted among 120 consecutive COPD patients recruited, in stable condition, at Nancy University Hospital, France. In parallel, 88 pulmonologists of the same geographical region were asked to respond to an on-line questionnaire on breathlessness management. Sixty four (53%) patients had severe breathlessness (modified Medical Research Council scale≥3), despite optimal inhaled medications for 94% of them; 40% had undergone pulmonary rehabilitation within the past 2?years. The severity of breathlessness increased with increasing airflow limitation. Breathlessness was associated with increased symptoms of anxiety, depression and with osteoporosis. No relation was found with other symptoms, exacerbation rate, or cardiovascular comorbidities. Among the patients with chronic breathlessness and Hospitalized Anxiety and/or Depression score??10, only 25% were treated with antidepressant or anxiolytic. Among the pulmonologists 46 (52%) answered to the questionnaire and expressed a high willingness to prescribe opioids forchronic breathlessness, which contrasted with the finding that none of these patients received such treatments against breathlessness. Treatment approaches to breathlessness and associated psychological distress are insufficient in COPD. This study highlights underuse of pulmonary rehabilitation and symptomatic treatment for breathlessness.
机译:呼吸困难是慢性阻塞性肺疾病(COPD)的突出症状。尽管包括药物和非药物干预措施在内的最佳治疗管理,许多COPD患者仍表现出明显的呼吸困难。慢性呼吸困难的定义是尽管对潜在疾病进行了最佳治疗,但仍持续存在呼吸困难。由于与慢性呼吸困难有关的严重残疾,几位作者推荐了包括阿片类药物在内的对症治疗。在慢性阻塞性肺病中慢性呼吸困难的患病率及其在常规临床实践中的处理方法尚未得到很好的研究。我们的目的是检查在真实的以三级医院为基础的队列研究中招募的COPD患者的患病率,相关特征和慢性呼吸困难的管理。在法国南希大学医院对病情稳定的120名连续COPD患者进行了前瞻性研究。同时,要求同一地理区域的88位肺病学家回答有关呼吸困难管理的在线问卷。尽管有94%的患者采用了最佳的吸入药物治疗,但仍有64例(53%)的患者出现严重的呼吸困难(经修正的医学研究委员会评分≥3);在过去2年内40%接受了肺部康复。呼吸困难的严重程度随着气流限制的增加而增加。呼吸困难与焦虑,抑郁和骨质疏松的症状增加有关。与其他症状,恶化率或心血管合并症没有关系。在患有慢性呼吸困难且住院焦虑和/或抑郁评分≥10的患者中,只有25%的患者接受过抗抑郁药或抗焦虑药治疗。在肺病学家中,有46位(52%)回答了问卷,并表示愿意开具阿片类药物预防慢性呼吸困难,这与发现这些患者均未接受此类抗呼吸困难治疗的发现形成对比。在COPD中,用于呼吸困难和相关心理困扰的治疗方法不足。这项研究强调了对呼吸困难的肺部康复和对症治疗的使用不足。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号